Kanaph Therapeutics Alternatives & Competitors

12 companies similar to Kanaph Therapeutics — We are the leader of next generation immuno-oncology and autoimmune diseases.

OSE Immunotherapeutics

Immuno-Oncology and Immuno-Inflammation - Breakthrough Immuno-Science for Patients

76 Grant $53.95M

Nantes, France

Biotechnology Medical Devices +1

Compare

Macomics

Macrophage Biology Revealed:Developing breakthrough approaches to macrophage activity to c...

24 Series A $7.44M

Edinburgh, United Kingdom

Biotechnology Health and Wellness +1

Nirogy Therapeutics

Pioneering innovative small molecules to disrupt metabolic and immune pathways, advancing...

2-10 Series A $18.50M

Biopharma Biotechnology +1

Biond Biologics Ltd

Biond - Innovative immunotherapies and a pioneering intracellular delivery for biologics f...

43 Series C $32.00M

Israel

Biotechnology Health Care +1

Track all Kanaph Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Innate Pharma

196 Post-IPO Secondary $276.10M

Marseille, France

Biopharma Biotechnology +1

Simcha Therapeutics

Overcoming biological challenges in clinically translatable pathways.

15 Series B $65.00M

New Haven, United States

Biotechnology Health and Wellness +2

FatiAbGen Inc.

Best in class multi-modality antibodies for difficult targets in high unmet need diseases...

9 Seed $3.00M

Korea South

Biopharma Biotechnology +1

KeifeRx

KeifeRx is a biopharmaceutical company finding disease-modifying treatments for neurodegen...

7 Series A $6.00M

Mclean, United States

Biopharma Biotechnology +1

HiFiBiO Therapeutics

HiFiBiO Therapeutics is a clinical stage biotherapeutics company mobilizing the human immu...

35 Series D $179.50M

Cambridge, United States

Biopharma Biotechnology +2

Arvinas

Leading the way in targeted protein degradation therapeutics

305 $585.85M

New Haven, United States

Biotechnology Health Care +2

Redx Pharma

Biotech company focusing on the discovery and development of novel targeted medicines to t...

39 Post-IPO Equity $78.90M

United Kingdom

Biotechnology Health Care +1

Alaunos Therapeutics

Attacking solid tumors with TCRs

10 Post-IPO Equity $293.39M

Houston, United States

Biotechnology Health and Wellness +1

About Kanaph Therapeutics

Kanaph Therapeutics is a leading player in next-generation immuno-oncology and autoimmune disease therapeutics. Established in 2019 in South Korea, the company focuses on drug discovery and pre-clinical stage biotech with a dual-track strategy for large and small molecule development. Their goal is to create first-in-c...

Business keywords

Immuno-oncology, Autoimmune Diseases, Drug Discovery, Pre-clinical Stage Biotech, Bi-specific Antibodies, Small Molecules, Immuno-stimulatory Activity, Tumor Micro-environment, Autoimmune Disease Pipeline, Complement Pathway, Angiogenesis, Immunotherapy, Therapeutics Development, Korea-based Biotech, Immune System Modulation

Frequently Asked Questions

Companies similar to Kanaph Therapeutics include OSE Immunotherapeutics, Macomics, Nirogy Therapeutics, Biond Biologics Ltd, Innate Pharma. They work in Biotechnology and Pharmaceutical and share Kanaph Therapeutics's focus on immunotherapy, drug discovery and immune system modulation.

Bounce Watch lists 12 companies that share Kanaph Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Kanaph Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Kanaph Therapeutics Profile OSE Immunotherapeutics Alternatives Macomics Alternatives Nirogy Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Kanaph Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.